215 related articles for article (PubMed ID: 7851831)
21. Cardioselective anti-ischemic ATP-sensitive potassium channel openers.
Atwal KS; Grover GJ; Ahmed SZ; Ferrara FN; Harper TW; Kim KS; Sleph PG; Dzwonczyk S; Russell AD; Moreland S
J Med Chem; 1993 Nov; 36(24):3971-4. PubMed ID: 8254626
[No Abstract] [Full Text] [Related]
22. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.
Lodge NJ; Halaka NN
J Pharmacol Exp Ther; 1993 Jun; 265(3):1399-405. PubMed ID: 8510016
[TBL] [Abstract][Full Text] [Related]
23. Influence of the alkylsulfonylamino substituent located at the 6-position of 2,2-dimethylchromans structurally related to cromakalim: from potassium channel openers to calcium entry blockers?
Florence X; Desvaux V; Goffin E; de Tullio P; Pirotte B; Lebrun P
Eur J Med Chem; 2014 Jun; 80():36-46. PubMed ID: 24763361
[TBL] [Abstract][Full Text] [Related]
24. The antitussive effect of cromakalim in rats is not associated with adenosine triphosphate sensitive K+ channels.
Kamei J; Iwamoto Y; Narita M; Suzuki T; Misawa M; Kasuya Y
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):201-10. PubMed ID: 8391711
[TBL] [Abstract][Full Text] [Related]
25. Activation of Ca(2+)-dependent K(+) current by nordihydroguaiaretic acid in porcine coronary arterial smooth muscle cells.
Yamamura H; Nagano N; Hirano M; Muraki K; Watanabe M; Imaizumi Y
J Pharmacol Exp Ther; 1999 Oct; 291(1):140-6. PubMed ID: 10490897
[TBL] [Abstract][Full Text] [Related]
26. Effects of JTV-506, a new K+ channel activator, on airway smooth muscle contraction and systemic blood pressure.
Ando T; Kume H; Urata Y; Takagi K
Clin Exp Allergy; 1997 Jun; 27(6):705-13. PubMed ID: 9208193
[TBL] [Abstract][Full Text] [Related]
27. Modulation of GABA transmission by diazoxide and cromakalim in the globus pallidus: implications for the treatment of Parkinson's disease.
Maneuf YP; Duty S; Hille CJ; Crossman AR; Brotchie JM
Exp Neurol; 1996 May; 139(1):12-6. PubMed ID: 8635558
[TBL] [Abstract][Full Text] [Related]
28. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
[TBL] [Abstract][Full Text] [Related]
29. Transmembrane currents in capillary endothelial cells are modulated by external Mg2+ ions.
Delpiano MA; Altura BM
Adv Exp Med Biol; 1996; 410():115-8. PubMed ID: 9030287
[No Abstract] [Full Text] [Related]
30. [New findings on calcium antagonism].
Ferrari R; Ceconi C; Curello S; Visioli O
Ann Ital Med Int; 1992; 7(3 Suppl):100S-111S. PubMed ID: 1338419
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological basis for use of calcium channel antagonists in hypertension.
Scriabine A; Kazda S; Garthoff B; Nickerson PA
Angiology; 1988 Jan; 39(1 Pt 2):94-9. PubMed ID: 2449099
[TBL] [Abstract][Full Text] [Related]
32. KATP--fact or artefact? New thoughts on the mode of action of the potassium channel openers.
Edwards G; Weston AH
Cardiovasc Res; 1994 Jun; 28(6):735-7; discussion 741-5. PubMed ID: 7923272
[No Abstract] [Full Text] [Related]
33. Mechanical and electrophysiological effects of cromakalim on the human urinary bladder.
Wammack R; Jahnel U; Nawrath H; Hohenfellner R
Investig Urol (Berl); 1994; 5():159-64. PubMed ID: 7719299
[No Abstract] [Full Text] [Related]
34. Ion channels, membrane lipids and cholesterol: a role for membrane lipid domains in arterial function.
Tulenko TN; Bialecki R; Gleason M; D'Angelo G
Prog Clin Biol Res; 1990; 334():187-203. PubMed ID: 1689856
[No Abstract] [Full Text] [Related]
35. The potassium channel opener BRL 38227 inhibits binding of [125I]-labelled endothelin-1 to rat cardiac membranes.
Waugh CJ; Dockrell ME; Haynes WG; Olverman HJ; Williams BC; Webb DJ
Biochem Biophys Res Commun; 1992 Jun; 185(2):630-5. PubMed ID: 1610355
[TBL] [Abstract][Full Text] [Related]
36. Functional changes in potassium channels in carotid arteries from stroke-prone spontaneously hypertensive rats.
Miyata N; Tsuchida K; Otomo S
Eur J Pharmacol; 1990 Jun; 182(1):209-10. PubMed ID: 2119312
[No Abstract] [Full Text] [Related]
37. Is there a therapeutic future for "potassium channel openers'?
Lawson K
Clin Sci (Lond); 1996 Dec; 91(6):651-63. PubMed ID: 8976800
[TBL] [Abstract][Full Text] [Related]
38. K+ channel openers decrease seizures in genetically epileptic rats.
Gandolfo G; Romettino S; Gottesmann C; van Luijtelaar G; Coenen A; Bidard JN; Lazdunski M
Eur J Pharmacol; 1989 Aug; 167(1):181-3. PubMed ID: 2506066
[No Abstract] [Full Text] [Related]
39. New drugs for renal colic therapy--in-vitro and animal experiments.
Zwergel U; Klaus E; Englert H; Zwergel T
Investig Urol (Berl); 1994; 5():225-9. PubMed ID: 7719311
[No Abstract] [Full Text] [Related]
40. Modulators of calcium and potassium channels: their effects on endothelin-1 binding to cardiac membranes.
Haynes WG; Waugh CJ; Dockrell ME; Olverman HJ; Williams BC; Webb DJ
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S154-7. PubMed ID: 7509930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
